CLINICAL_TRIALS
trial_result
· 2021-01-05
Clinical Trial Update: Anti-LPS Antibody Treatment for Pediatric NAFLD [Phase 2]
Summary
Phase 2 trial update for anti-LPS antibody in pediatric NAFLD has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Miriam Vos, MD | Conditions: Nonalcoholic Fatty Liver Disease (NAFLD) | Phase 2 | Status: COMPLETED | Results posted: 2021-01-05